Praxis share price halved after essential tremor fail, but biotech still plans phase 3
https://www.fiercebiotech.com/biotech/praxis-shaken-essential-tremor-fail-still-plans-phase-3
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.